Status:
RECRUITING
High Frequency ABR
Lead Sponsor:
Cardiff and Vale University Health Board
Collaborating Sponsors:
University of Manchester
Conditions:
Hearing Loss, High-Frequency
Eligibility:
All Genders
18+ years
Brief Summary
This study is looking at a method called 'ABR', which measures the electrical activity in the brain (brain waves) when we hear sounds. This study will look at the electrical activity in participants b...
Detailed Description
The most common way of measuring how good someone's hearing is, is to play them sounds at different levels and ask them to respond when they can hear it, for example, by pressing a button when they he...
Eligibility Criteria
Inclusion
- Participant is able and willing to give informed consent.
- Participant is over 18.
- Hearing in the test ear of ≤90dBSPL at 6 kHz and 8 kHz in PTA
- Able and willing to perform PTA reliably.
- Able and willing to sit still comfortably for the duration of an ABR.
Exclusion
- Any conductive element to hearing loss (air-bone gap on PTA of \>10dB).
- Occluding wax, TM perforations or ear infections (on otoscopy)
- CI or BAHA user
- Abnormal outer of middle ear
Key Trial Info
Start Date :
December 18 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06161857
Start Date
December 18 2023
End Date
June 1 2024
Last Update
February 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiff and Value University Health Board
Cardiff, United Kingdom